PI
IMUX icon

PFG Investments’s Immunic IMUX Stock Holding History

PFG Investments’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,050
Closed -$5.6K – 1225
2025
Q4 		$5.6K Hold
1,050
– – ﹤0.01% 1149
2025
Q3 		$9.26K Hold
1,050
– – ﹤0.01% 1108
2025
Q2 		$7.32K Hold
1,050
– – ﹤0.01% 1042
2025
Q1 		$11.4K Hold
1,050
– – ﹤0.01% 1006
2024
Q4 		$10.5K Hold
1,050
– – ﹤0.01% 1020
2024
Q3 		$17.3K Buy
+1,050
New +$14.9K ﹤0.01% 1001

Other funds holding IMUX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

PFG Investments's IMUX Position: Q1 2026 in Review

PFG Investments sold out of Immunic (IMUX) in Q1 2026, closing a stake of 1,050 shares — an estimated $5.6K sold.

PFG Investments first reported a position in IMUX in Q3 2024 and held it in 6 quarters. The position peaked at $17.3K in Q3 2024. 75 funds tracked by Wall St. Rank hold IMUX as of Q1 2026.

  • PFG Investments reported no remaining Immunic position as of Q1 2026 after selling out during the quarter.
  • PFG Investments sold 1,050 Immunic shares in Q1 2026, an estimated $5.6K.
  • PFG Investments first reported a position in Immunic in Q3 2024 and held it in 6 quarters.
  • PFG Investments's Immunic position peaked at $17.3K in Q3 2024.
  • 75 funds tracked by Wall St. Rank held Immunic as of Q1 2026.

Based on PFG Investments's 13F filing for Q1 2026, filed 27 Apr 2026.